Nutritional Status Indicators as a Predictor of Achieving Remission at Week 14 during Vedolizumab Therapy in Patients with Ulcerative Colitis: A Pilot Study

Nutritional Status Indicators as a Predictor of Achieving Remission at Week 14 during Vedolizumab Therapy in Patients with Ulcerative Colitis: A Pilot Study

<b>Background</b>: The loss of response or failure to achieve remission to vedolizumab in ulcerative colitis (UC) patients is currently a major clinical problem. Recently, Nutritional Risk Index (NRI), Controlling Nutritional Status (CONUT), and Malnutrition Universal Screening Tool (MUS...

Full description

Bibliographic Details
Main Authors: Aleksandra Sobolewska-Włodarczyk, Ewa Walecka-Kapica, Marcin Włodarczyk, Anita Gąsiorowska
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Nutrients
Subjects:
ulcerative colitis
vedolizumab
nutritional status
predictive biomarkers
treatment outcomes
Online Access:https://www.mdpi.com/2072-6643/15/1/240

Internet

https://www.mdpi.com/2072-6643/15/1/240

Similar Items